Home › Enlarged Prostate (BPH) › NCT07632742

Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial

MOSES 2.0 vs Quanta Magneto 150 Holmium Laser for Holmium Laser Enucleation of the prostate-a Randomized Controlled Trial

Who can join

Ages 18 to 100 · Men · Healthy volunteers welcome

Inclusion Criteria:

* Undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms
* Internet access and a device to complete postoperative questionnaires (smartphone, tablet, laptop or desktop computer)

Exclusion Criteria:

* Patients who lack decisional capacity
* Patients unable to read/speak English
* Patients who are on a blood thinner (anticoagulation medication)
* Patients who do not have internet access to complete postoperative surveys

About the study

The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.

What is being tested

• Magneto 150 holmium laser (device)
• Moses 2.0 holmium laser (device)

Sponsor: Northwestern University · Participants: 180 · Started: 2026-06

Contact the study team

• Alyssa McDonald, MPH · Phone: 312-695-8146

Official record on ClinicalTrials.gov — NCT07632742

Locations in the U.S.

Conditions

• Enlarged Prostate (BPH)

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.